CASSELLA JAMES V (Chief Development Officer) sold 5.4% of their position (10.11K shares) of CONCERT PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $84.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/31/2023ACC: 0001209191-23-005620
Officer· Chief Development Officer
Since Jan 2019
-10.11K
Net shares
Net seller
$84.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
10.11K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−10.11K
Price / share
$8.35
Trade value
$84.39K
% of position
5.4%
1/30/2023
186.93K→176.82K
Total
Net shares
−10.11K
Net value
-$84.39K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/30/2023 | S · Sale | −10.11K | $8.35 | $84.39K | 5.4% | 186.93K | 176.82K |
| Total | −10.11K | -$84.39K | ||||||
Derivative Transactions0
No derivative transactions reported